Corcept Therapeutics (CORT) Tax Provisions (2017 - 2026)
Corcept Therapeutics (CORT) posted Tax Provisions of $2.9 million for Q2 2026, up 122.65% sequentially from -$13.0 million in Q1 2026, and up 184.11% YoY from $1.0 million in Q2 2025.
Corcept Therapeutics (CORT) Tax Provisions (2017 - 2026) Analysis & Trends
Corcept Therapeutics has reported Tax Provisions for 10 years, with the latest figure at $2.9 million in Q2 2026.
- Quarterly Tax Provisions rose 184.11% year-over-year to $2.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$28.9 million (down 284.02% YoY) and the FY2025 annual result came in at -$33.2 million, down 263.62% from the prior year.
- Tax Provisions improved to $2.9 million in Q2 2026 per CORT's latest filing, from -$13.0 million in the prior quarter.
- Over five years, Tax Provisions peaked at $7.7 million in Q4 2022 and troughed at -$14.4 million in Q4 2025.
- A 5-year average of $570000.0 and a median of $3.5 million in 2022 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions soared 412.16% in 2023, then slumped 1314.36% in 2025.
- Over 5 years, Tax Provisions stood at $7.7 million in 2022, then slipped by 29.4% to $5.4 million in 2023, then slumped by 78.14% to $1.2 million in 2024, then plunged by 1314.36% to -$14.4 million in 2025, then jumped by 120.48% to $2.9 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $2.9 million, -$13.0 million, and -$14.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.94 Mn |
| Mar 31, 2026 | -13.00 Mn |
| Dec 31, 2025 | -14.38 Mn |
| Sep 30, 2025 | -4.43 Mn |
| Jun 30, 2025 | -3.50 Mn |
| Mar 31, 2025 | -10.93 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 5.73 Mn |
| Jun 30, 2024 | 6.11 Mn |
| Mar 31, 2024 | 7.23 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 5.01 Mn |
| Jun 30, 2023 | 5.40 Mn |
| Mar 31, 2023 | 2.60 Mn |
| Dec 31, 2022 | 7.67 Mn |
| Sep 30, 2022 | -1.60 Mn |
| Jun 30, 2022 | 4.70 Mn |
| Mar 31, 2022 | 4.10 Mn |
| Dec 31, 2021 | 4.68 Mn |
| Sep 30, 2021 | 5.83 Mn |